STOCK TITAN

Modular Medical (MODD) director awarded options and shares as board compensation

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Modular Medical, Inc. director Steven G. Felsher reported compensation-related equity awards. He received an option to purchase 250 shares of common stock at an exercise price of $4.55 per share, fully vested and exercisable on the grant date, under the Outside Director Compensation Plan. He was also granted 25 shares of common stock with no purchase price. After this grant, he directly owns 8,473 shares of common stock. The reported share amounts reflect the impact of a 1-for-30 reverse stock split effective March 31, 2026.

Positive

  • None.

Negative

  • None.
Insider FELSHER STEVEN G
Role Director
Type Security Shares Price Value
Grant/Award Option to purchase common stock 250 $0.00 --
Grant/Award Common Stock 25 $0.00 --
Holdings After Transaction: Option to purchase common stock — 250 shares (Direct); Common Stock — 8,473 shares (Direct)
Footnotes (1)
  1. These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
Option grant size 250 shares Option to purchase common stock granted March 31, 2026
Option exercise price $4.55 per share Exercise price for director stock option
Option expiration March 31, 2036 Expiration date of director stock option
Stock grant size 25 shares Common stock granted at $0.00 as compensation
Post-transaction common shares 8,473 shares Total direct common stock held after grant
Reverse stock split ratio 1-for-30 Reverse split of common stock effective March 31, 2026
Outside Director Compensation Plan financial
"These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan."
1-for-30 reverse stock split financial
"Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026."
fully vested and exercisable financial
"the option was fully vested and exercisable on the grant date."
beneficial ownership financial
"column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
derivative security financial
"beneficial ownership of the "class" of derivative security reported in column 1."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FELSHER STEVEN G

(Last)(First)(Middle)
C/O MODULAR MEDICAL, INC.
10740 THORNMINT ROAD

(Street)
SAN DIEGO CALIFORNIA 92127

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026A25A(1)8,473(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to purchase common stock(2)$4.5503/31/2026A25003/31/202603/31/2036Common Stock250(3)250(4)D
Explanation of Responses:
1. These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.
2. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.
3. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.
4. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
/s/ James Sullivan, attorney-in-fact for Steven Felsher04/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Modular Medical (MODD) report for Steven G. Felsher?

Modular Medical reported that director Steven G. Felsher received an option for 250 shares at $4.55 per share and a grant of 25 common shares, both issued as compensation under the company’s Outside Director Compensation Plan on March 31, 2026.

Were the MODD Form 4 transactions open-market buys or sales?

The MODD Form 4 transactions were compensation grants, not open-market trades. Both the 250-share option and the 25-share common stock award were issued at a price of $0.00, reflecting grants under the Outside Director Compensation Plan rather than market purchases or sales.

What are the key terms of Steven G. Felsher’s stock option from Modular Medical (MODD)?

Steven G. Felsher received an option to purchase 250 shares of MODD common stock at an exercise price of $4.55 per share, expiring March 31, 2036. The option was granted under the Outside Director Compensation Plan and was fully vested and exercisable on the grant date.

How many Modular Medical (MODD) shares does Steven G. Felsher hold after this Form 4?

Following the reported transactions, Steven G. Felsher directly owns 8,473 shares of Modular Medical common stock. This figure reflects his total direct beneficial ownership of common shares after receiving the 25-share grant on March 31, 2026, according to the Form 4.

How did the reverse stock split affect the MODD share amounts reported in this Form 4?

The Form 4 states that the share amounts reflect a 1-for-30 reverse stock split of Modular Medical’s common stock effective March 31, 2026. This means the reported 8,473 common shares and the grant quantities are presented on a post-split basis in the filing.

What is the nature of the equity awards granted to the MODD director on March 31, 2026?

Both awards were made as outside director compensation. The company issued 25 common shares at no cost and granted an immediately vested option covering 250 common shares at a $4.55 exercise price, consistent with the terms of the Outside Director Compensation Plan.